We are looking for you, the entrepreneur who is passionate about advancing the development of their innovation and determined to bridge the product development “valley of death” or the gap between academic research and commercialization.
Secondly, expanding on our core expertise areas, we want to extend
the scientific reach into adjacent therapeutic and technology areas.
This is also the place where we seek to advance novel drug targets or
therapeutic approaches, biological pathways, and drug discovery
technology and therapeutic modalities.
The challenge is open for up-and-coming life sciences and biotech start-up ventures to submit their research/company proposal. The application deadline is 12pm Central European Time on 23 October 2022.
A panel of experts will review the application and select the most promising solutions to be presented on pitch day.
The pitch day where 2-6 startups will be selected to present their work as part of the programme, will take place in Paris in week 47 and in Heidelberg in week 46.
The selected startup(s) will be supported by BioLabs to take up residency and bench space on their premises, between November 2022 and December 2022 (dates subject to change)
After months of hard work, the teams will participate in an introduction day at BioLabs in 2023 to showcase their work to the wider Novo Nordisk organization.